Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Forma Therapeutics Holdings, Inc. | SVP, Commercial Officer | Common Stock | 0 | $5.05 | Oct 14, 2022 | Direct | |
Forma Therapeutics Holdings, Inc. | SVP, Commercial Officer | Stock Option (Right to Buy) | 0 | Oct 14, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
FMTX | Forma Therapeutics Holdings, Inc. | Oct 14, 2022 | 8 | $0 | 4 | Oct 14, 2022 | SVP, Commercial Officer |
FMTX | Forma Therapeutics Holdings, Inc. | Feb 28, 2022 | 2 | $0 | 4 | Mar 2, 2022 | SVP, Commercial |
FMTX | Forma Therapeutics Holdings, Inc. | Feb 23, 2022 | 1 | -$37.5K | 4 | Feb 25, 2022 | SVP, Commercial |
FMTX | Forma Therapeutics Holdings, Inc. | Nov 15, 2021 | 0 | $0 | 3/A | Sep 19, 2022 | SVP, Commercial |